Pharmaceuticals

Showing of 1 - 20 from 67 results
Pharmaceuticals - Total results - 67
From the COVID-19 pandemic, experts have a roadmap to lowering the costs of medicine
World

From the COVID-19 pandemic, experts have a roadmap to lowering the costs of medicine

The decades-long trend of rising drug prices, described by Eroom’s Law, is in part a result of regulatory inefficiencies.

Caught in deadly race with new COVID strain, Britain 'gambles' with mix-and-match vaccine regimen
World

Caught in deadly race with new COVID strain, Britain 'gambles' with mix-and-match vaccine regimen

Scientists have slammed the new guidance which allows for the interchange of vaccines, if the second dose of the vaccine originally received is not available, saying officials have abandoned science and are just trying to 'guess their way out of a mess'

MIT researchers create gel that mimics camel fur, could help keep objects cool for days
science

MIT researchers create gel that mimics camel fur, could help keep objects cool for days

Tests have shown that this new gel, which is less than half-inch thick, can provide cooling of more than sever degrees Celsius for five times longer than hydrogel alone.

India pledges $15-mn at virtual global vaccine summit; funds to be used for immunisation programmes across the world
World

India pledges $15-mn at virtual global vaccine summit; funds to be used for immunisation programmes across the world

Prime Minister Narendra Modi on Thursday pledged $15-million as India's contribution to the vaccines alliance GAVI at the Global Vaccine Summit hosted by the UK

Lupin Q4 results: Consolidated net profit rises 35% to Rs 390 cr; income from operations marginally down
Business

Lupin Q4 results: Consolidated net profit rises 35% to Rs 390 cr; income from operations marginally down

Drug firm Lupin has reported a 34.55 percent rise in its consolidated net profit to Rs 389.63 crore for the quarter ended March 2020 mainly on account of robust sales in the domestic market and lower tax expenses

Lupin gets inspection closure report from USFDA for Pithampur manufacturing plant in Madhya Pradesh
Business

Lupin gets inspection closure report from USFDA for Pithampur manufacturing plant in Madhya Pradesh

Drug maker Lupin on Thursday said the US health regulator has closed the inspection of its manufacturing facility in Pithampur, Madhya Pradesh

Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions
Business

Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions

With pharmaceutical supply chains under immense pressure due to COVID-19, China's role as a global ingredient producer has come under scrutiny, Fitch Solutions has said

Lupin's Mandideep Unit II facility in Madhya Pradesh receives EIR from USFDA
Business

Lupin's Mandideep Unit II facility in Madhya Pradesh receives EIR from USFDA

Pharma major Lupin on Wednesday said it has received an establishment inspection report (EIR) from the US health regulator for its Mandideep Unit II facility in Madhya Pradesh

Lupin gets EIR from USFDA for Nagpur plant; MD says committed to enhance compliance, quality standards at all sites
Business

Lupin gets EIR from USFDA for Nagpur plant; MD says committed to enhance compliance, quality standards at all sites

Drug maker Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Nagpur

Coronavirus Outbreak: The story of a premier US pharma company that became a COVID-19 'super spreader'
World

Coronavirus Outbreak: The story of a premier US pharma company that became a COVID-19 'super spreader'

On the first Monday in March, Michel Vounatsos, chief executive of the drug company Biogen, appeared in good spirits. The company’s new Alzheimer’s drug was showing promise after years of setbacks. Revenues had never been higher

Tussle over hydroxychloroquine puts India's neighbourhood first policy at odds with efforts to appease Trump
India

Tussle over hydroxychloroquine puts India's neighbourhood first policy at odds with efforts to appease Trump

On Tuesday, India lifted an export ban on 24 active pharmaceutical ingredients, believed to be critical in the battle against coronavirus

Coronavirus may impact India's March quarter GDP growth by 0.20% after epidemic hits imports from China for crucial sectors: Report
Business

Coronavirus may impact India's March quarter GDP growth by 0.20% after epidemic hits imports from China for crucial sectors: Report

The brokerage cut its fiscal 2020-21 real GDP growth estimate marginally to 5.6% as against the previous estimate of 5.7%, but added that there will be a recovery in the next financial year.

Govt working on incentives to promote industrial development in J&K region: Commerce Minister Piyush Goyal
Business

Govt working on incentives to promote industrial development in J&K region: Commerce Minister Piyush Goyal

The government is working on several incentives and steps to promote industrial development in the Jammu and Kashmir region, Commerce and Industry Minister Piyush Goyal said on Wednesday

Jan Aushadhi scheme may disrupt domestic pharmaceutical market: Edelweiss report
Business

Jan Aushadhi scheme may disrupt domestic pharmaceutical market: Edelweiss report

The Jan Aushadhi scheme, under which the government provides quality medicines at affordable rates may disrupt around 20 percent of Indian pharmaceutical market sales, says a report

Exports up 2.44% to $26.67 bn in February on higher shipments in pharma, engineering sectors; trade deficit narrows
Business

Exports up 2.44% to $26.67 bn in February on higher shipments in pharma, engineering sectors; trade deficit narrows

Imports declined by 5.4 percent to $36.26 billion in the last month, narrowing the trade deficit to $9.6 billion. The gap between imports and exports was $12.3 billion in February 2018.

A super-spicy Moroccan cactus offers hope to end our dependence on opioids
science

A super-spicy Moroccan cactus offers hope to end our dependence on opioids

The plant offers many benefits over today's painkillers, including not being addictive: Study.

Lupin June quarter net profit dips 43% to Rs 203 cr, hit by drop in sales in US and Japan
Business

Lupin June quarter net profit dips 43% to Rs 203 cr, hit by drop in sales in US and Japan

"The first quarter of FY2019 has been subdued, primarily on account of the US and Japan," Lupin Ltd Managing Director Nilesh Gupta said in a statement.

India's trade deficit widens to more than five-year high of $16.6 bn; imports soar by 21.31% to $44.3 bn
Business

India's trade deficit widens to more than five-year high of $16.6 bn; imports soar by 21.31% to $44.3 bn

The trade deficit in June 2018 is the highest since November 2014 when the gap was $16.86 billion. The deficit in June 2017 stood at $12.96 billion

New Alzheimer's drug from Biogen and Eisai shows promise in mid-stage trials
science

New Alzheimer's drug from Biogen and Eisai shows promise in mid-stage trials

Currently prescribed drugs to Alzheimer's patients offer symptomatic relief, but do not slow, stop or reverse the damage done.

Lupin to launch nearly 30 products in US market this fiscal, says managing director Nilesh Gupta
Business

Lupin to launch nearly 30 products in US market this fiscal, says managing director Nilesh Gupta

Lupin currently has 162 abbreviated new drug applications (ANDAs) pending approval with the US Food and Drug Administration (USFDA)